Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update | SpringerLink
New insights in the mode of action of (+)-erythravine and (+)-11α-hydroxy-erythravine alkaloids - ScienceDirect
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents | Scientific Reports
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents | Scientific Reports
The mechanism of action of retigabine (ezogabine), a first‐in‐class K+ channel opener for the treatment of epilepsy - Gunthorpe - 2012 - Epilepsia - Wiley Online Library
PDF) Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents | Scientific Reports
Potent KCNQ2/3-Specific Channel Activator Suppresses In Vivo Epileptic Activity and Prevents the Development of Tinnitus | Journal of Neuroscience
Retigabine inhibits the KV2-mediated component of the outward current... | Download Scientific Diagram
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink
Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers | PNAS
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents | Scientific Reports
Retigabine | C16H18FN3O2 - PubChem
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents | Scientific Reports
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. - Abstract - Europe PMC
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models | Journal of Pharmacology and Experimental Therapeutics